Angene Chemical
Draw
|
Currency :
Home Products

AG0039LA

108736-35-2 | (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

Chemical structure of (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide, CAS 108736-35-2
AG0039LA
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 108736-35-2
Catalog Number AG0039LA(AGN-PC-0OYTX8)
Chemical Name (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
IUPAC Name 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
InChI InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)
InChI Key PUDHBTGHUJUUFI-UHFFFAOYSA-N
MDL Number MFCD03424071
Molecular Formula C54H69N11O10S2
Molecular Weight 1096.3234
SMILES C(C=1C=2C(NC1)=CC=CC2)[C@H]3NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC([C@@H](CC5=CC6=C(C=C5)C=CC=C6)N)=O)CSSC[C@@H](C(N[C@@H]([C@@H](C)O)C(N)=O)=O)NC(=O)[C@H]([C@@H](C)C)NC(=O)[C@H](CCCCN)NC3=O
Synonyms
188Re-lanreotide, 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide, BIM 23014, BIM 23014C, BIM-23014, DC 13-116, DC-13-116, DC13-116, L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide, lanreotide, lanreotide acetate, lanreotide-SR, Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)-Thr-NH2, Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2, naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide, naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2, Somatulin, Somatulina, Somatuline, Lanreotide, Lanreotide acetate, 127984-74-1, Angiopeptin acetate, Somatuline, Somatulin, 108736-35-2, DC 13-116, Autogel, BIM 23014, Bim-23014, Lanreotide [INN:BAN], Lanreotidum [INN-Latin], Lanreotida [INN-Spanish], 10-(4-Aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide, Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2, 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide, L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide, C54H69N11O10S2, AC1L2FZT, SCHEMBL34091, GTPL2031, SCHEMBL14802383, CTK8G7572, PUDHBTGHUJUUFI-UHFFFAOYSA-N, (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide, DB06791, NCGC00181321-01, AK608077, AN-33681, L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide, LS-153748, LS-172394, 33928-EP2272827A1, 33928-EP2275420A1, 33928-EP2295055A2, 33928-EP2295416A2, 33928-EP2295426A1, 33928-EP2295427A1, 33928-EP2298748A2, 33928-EP2298764A1, 33928-EP2298765A1, 33928-EP2305642A2, 33928-EP2311453A1, 33928-EP2311808A1, 33928-EP2311829A1, L000343, 10-(4-aminobutyl)-19-[[2-amino-3-(2-naphthyl)propanoyl]amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide, 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2 inverted exclamation marku7)-disulfide acetate, 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-->7)-disulfide acetate, Lanreotide; Angiopeptin; 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-7)-disulfide; 127984-74-1, Angiopeptin, Lanreotida, Lanreotidum, Somatulina, Ipstyl, Lanreotide Autogel, lanreotide-SR, Somatuline Depot, Somatulin-Autogel, Somatuline Autogel, 188Re-lanreotide, Somatuline lp (TN), Somatuline Depot Injection, D0M2YE, D0V1SB, UNII-IEU56G3J9C, Lanreotide acetate [USAN], UNII-0G3DE8943Y, BIM 23014C, BIM-23014C, CID71349, ACN-057303, C54H69N11O10S2.xC2H4O2, DC13-116, C54-H69-N11-O10-S2, DC-13-116, Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2, naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2, C060347, C54-H69-N11-O10-S2.x-C2-H4-O2, |A-(2-Naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr amide [Disulfide Bridge: 2 C7], 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide, naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide, 118992-92-0, 3-(2-Naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, cyclic (2->7)-disulfide, acetate (salt),

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited